Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
OVID · against 1,216 other Healthcare companies
Ranked #287 of 1,217 · scores higher than 76% of peers
Bars: peers in each 10-point band of the growth score121 peers with a growth score of 70–79, including OVID · Click a bar to see the companies
Mainly thanks to its 3-year revenue growth, which is stronger than most Healthcare peers.
| Metric | OVID | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 1,243 reported | -76.2% | 6.1% | 2% | 33% | |
| Earnings per share growthHigher is better · 682 reported | Not reported | 9.7% | — | — | 33% |
| 3-year revenue growthHigher is better · 1,192 reported | 99.8% | 5.8% | 96% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 464M USD | 100 | 53 | |
| 3 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 3 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 3 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 287 | 521.3B INR (≈$6.3B) | 76 | 69 | |
| 287 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
| 1.1B CAD (≈$807M) |
| 76 |
| 60 |
| 287 | 871.6B INR (≈$10.5B) | 76 | 66 |
| 287 | 1.2B USD | 76 | 39 |
| 287 | 469M USD | 76 | 45 |
| 287 | 660M GBP (≈$858M) | 76 | 35 |
| 287 | 1.5B USD | 76 | 59 |
| 287 | 48.9B USD | 76 | 54 |
| 287 | 52.7B EUR (≈$58.0B) | 76 | 71 |